Interim Clinical Considerations for Use of COVID-19 Vaccines Appendices References and Previous Updates

Centers for Disease Control and Prevention. (2023). Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates. (Added 12/30/2020.) U.S. Department of Health and Human Services.
This page offers clinical considerations for the Pfizer-BioNTech, Moderna, Novavax, and Johnson & Johnson/Janssen COVID-19 vaccines related to updated vaccination of those who previously received a COVID-19 vaccine outside the United States and vaccine administration errors and deviations.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.